Drug profile · INN
pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)
HUMENZA
- Patents linked
- 0
- News articles
- 0
Quick answer
pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted) (HUMENZA) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)
Brand HUMENZA
ATC code J07BB02
Frequently asked questions
What is pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)?
pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted) (HUMENZA) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted)?
HUMENZA is a marketed brand name for pandemic influenza vaccine (h1n1) (split virion, inactivated, adjuvanted). Check FDA Drugs@FDA for the current US label holder and prescribing information.